- September 08, 2026
This article is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Do not stop or change any prescription medication without consulting your provider.
The most common side effects of Ozempic are nausea, vomiting, diarrhea, abdominal pain, and constipation. These usually appear when starting the medication or increasing the dose, and improve over time for most people. A smaller number of side effects are serious and worth calling your provider about right away. This guide covers both.
A Quick Note on Ozempic vs Wegovy
Ozempic and Wegovy contain the same active ingredient, semaglutide, and are made by the same manufacturer, Novo Nordisk. According to the FDA (Food and Drug Administration) prescribing information, Ozempic is approved for type 2 diabetes and to reduce the risk of certain heart and kidney complications in diabetic patients. Wegovy is approved for chronic weight management in adults and adolescents who meet specific BMI (Body Mass Index) criteria.
In real clinical practice, providers may prescribe either brand depending on a patient’s health history, insurance coverage, and clinical judgment. Off-label prescribing (using an approved drug for a condition it wasn’t specifically approved for) is legal and common across medicine, and Drugs.com’s Ozempic reference confirms it happens routinely with Ozempic when a patient’s situation calls for it.
Because both medications use the same molecule at overlapping doses, the side-effect profile is largely the same. For the fuller picture on how providers choose between the two, see Windermere Medical Group’s GLP-1 weight loss treatment program.
Most Common Side Effects of Ozempic
- Nausea. The most frequently reported side effect. Often mild but can be intense in the first few days after a dose change.
- Vomiting. Less common than nausea, but more likely at higher doses or if nausea isn’t managed early.
- Diarrhea. Can appear early in treatment and typically improves with time.
- Abdominal pain or discomfort. Usually mild and short-lived; persistent or severe pain deserves a call to your provider.
- Constipation. Common enough that many providers proactively recommend fiber and hydration when starting.
When Do Side Effects Start, and How Long Do They Last?
Gastrointestinal side effects are most common when starting Ozempic and after each dose increase. Per the FDA prescribing information, these symptoms decrease over time in the majority of patients. This is why providers use gradual titration, starting at a low dose and stepping up over several weeks so the body has time to adjust.
Many people notice their symptoms follow the weekly rhythm of the injection: mild nausea or reduced appetite in the day or two afterward, easing by mid-week. If your pattern is dramatically different, or if symptoms get worse over time instead of better, that’s worth flagging to your care team.
How to Manage the Common Side Effects
| Side Effect | What Often Helps |
| Nausea | Eat smaller meals more often; avoid greasy, spicy, or overly sweet foods; stay well hydrated; try eating protein first; notify your provider if it disrupts daily life |
| Constipation | Increase dietary fiber gradually, drink more water, stay physically active; ask about a stool softener if the changes aren’t enough |
| Heartburn or reflux | Avoid eating within 2 to 3 hours of lying down; sleep with your head slightly elevated; smaller portions |
| Fatigue | Prioritize hydration, adequate protein, and consistent sleep; blood-sugar shifts can also cause fatigue in patients with diabetes |
| Injection-site bruising | Rotate injection sites; follow the pen instructions closely |
Serious Side Effects and FDA Warnings
Serious side effects of Ozempic are less common than the gastrointestinal ones but important to recognize. The FDA prescribing information lists several under Warnings and Precautions, including a boxed warning on thyroid tumors, pancreatitis, gallbladder disease, kidney injury, hypoglycemia, worsening diabetic retinopathy, and severe allergic reactions. The label was also updated in September 2023 to add ileus (intestinal obstruction) under postmarketing experience.
Thyroid C-cell tumors (FDA boxed warning)
In rodent studies, semaglutide caused thyroid C-cell tumors at clinically relevant exposures. It is unknown whether Ozempic causes these tumors in humans. Ozempic is contraindicated (not to be used) in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Symptoms to report to your provider include a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath.
Pancreatitis
Inflammation of the pancreas has been reported in clinical trials. Symptoms include severe abdominal pain that may radiate to the back, often with nausea and vomiting. If pancreatitis is suspected, Ozempic should be discontinued promptly. Do not restart it without your provider’s guidance.
Gallbladder disease
Gallstones and gallbladder inflammation have occurred in patients taking Ozempic, particularly during rapid weight loss. Symptoms include severe pain in the upper right abdomen, fever, or yellowing of the skin or eyes.
Acute kidney injury
Severe or persistent nausea, vomiting, or diarrhea can lead to dehydration, which can in turn cause acute kidney injury or worsen existing kidney problems. Staying hydrated is genuinely protective here, and severe GI symptoms should not be ignored.
Hypoglycemia (low blood sugar)
Ozempic alone typically does not cause low blood sugar, but the risk increases when combined with insulin or sulfonylureas. Providers often adjust those other medications when starting Ozempic. Symptoms include shakiness, sweating, confusion, and rapid heartbeat.
Worsening diabetic retinopathy
In patients with diabetes and existing diabetic eye disease, rapid improvement in blood sugar (which Ozempic can cause) has been associated with worsening retinopathy. Patients with a history of retinopathy should stay current with their eye exams.
Serious allergic reactions
Rare but possible. Signs include swelling of the face, lips, tongue, or throat; severe rash; difficulty breathing; or fainting. These are 911 situations, not office-visit situations.
Ileus (intestinal obstruction)
Added to the FDA label in September 2023 under postmarketing experience. Ileus is a stoppage of movement through the intestines. Symptoms include severe abdominal pain, bloating, vomiting, and being unable to pass gas or stool. This is an emergency.
Gastroparesis (delayed stomach emptying)
Because GLP-1 medications intentionally slow stomach emptying, some patients experience prolonged delayed emptying. Symptoms include persistent fullness after small meals, nausea that doesn’t ease, and vomiting undigested food. Discuss with your provider; dose changes or medication changes are options.
What the FDA Has Said About Reported Mental Health Effects and Hair Loss
There has been public discussion about whether Ozempic and other GLP-1 medications cause mental health effects or hair loss. The clearest current source on the mental health question is the FDA’s January 2024 safety communication, which stated that after reviewing reports of suicidal thoughts and self-harm in patients taking GLP-1 receptor agonists, the agency has not established a causal link. The FDA continues to monitor.
For hair loss, reports appear in FDA’s adverse event reporting system, but as of the most recent FDA communications, no causal link has been established. This does not mean nothing is happening for individual patients, only that a population-level causal connection has not been confirmed.
If you experience mood changes, new or worsening anxiety or depression, or thoughts of self-harm while taking Ozempic, contact your provider right away. If you are in immediate crisis in the US, call or text 988 to reach the Suicide and Crisis Lifeline.
Long-Term Side Effects and Ongoing Research
Ozempic has been FDA-approved since 2017, so long-term real-world data now spans several years. The ongoing areas of clinical interest, tracked in the FDA prescribing information and postmarketing surveillance, include thyroid effects, pancreatitis risk over time, gastroparesis, and gallbladder disease. These are areas of active research rather than settled questions, which is another argument for continuing physician-supervised care rather than open-ended self-directed use.
What Happens When You Stop Taking Ozempic
Because semaglutide has a half-life of roughly a week, its effects taper gradually rather than stop the moment you skip a dose. Appetite and blood-sugar effects fade over the following weeks. Weight regain is common if lifestyle changes aren’t maintained, and per Drugs.com’s Ozempic reference, stopping Ozempic (especially when it’s part of a diabetes regimen) should be planned with your provider, not done abruptly.
Are Side Effects Different for Women and Men?
The FDA label does not identify sex-specific side effects for Ozempic. Real-world observational reports suggest women may be more likely to report nausea and gastrointestinal symptoms, and men may more often report reduced appetite and fatigue, but these come from post-marketing observations rather than the label itself.
Anyone, of any sex, who notices a meaningful change in menstrual patterns, sexual function, mood, or energy while taking Ozempic should discuss it with their provider. Attribution can be tricky (weight loss itself causes many of these changes independently of the medication), which is exactly why a supervising provider is useful.
Ozempic vs Mounjaro Side Effects
Ozempic (semaglutide) and Mounjaro (tirzepatide) are both prescription injections used in weight management and, for their respective FDA-approved indications, diabetes. They share the same broad gastrointestinal side-effect profile: nausea, vomiting, diarrhea, and abdominal pain top the list for both.
Head-to-head trial data show tirzepatide tends to produce slightly higher rates of gastrointestinal side effects at maintenance doses but also greater average weight loss. Which one is better tolerated is an individual clinical question, not a general one. For how tirzepatide dosing works and how providers step patients up gradually to minimize side effects, see our guide to tirzepatide titration and how doctors adjust the dose for tolerability.
When to Call Your Doctor, and When to Go to the ER
Most side effects can be handled during a regular office visit or a telehealth check-in. A smaller number are emergencies. Here’s the practical dividing line, drawn from the FDA label’s warnings section.
| Call your care team | Go to the ER (call 911) |
| Nausea, vomiting, or diarrhea that disrupts daily life or lasts more than a few days | Severe abdominal pain radiating to the back (possible pancreatitis) |
| Signs of dehydration (very dark urine, dizziness on standing, minimal urination) | Swelling of the face, lips, tongue, or throat; difficulty breathing (severe allergic reaction) |
| A new lump or swelling in the neck, hoarseness, or trouble swallowing | Severe abdominal pain with vomiting and inability to pass gas or stool (possible ileus) |
| Blood-sugar readings that fall outside your target range | Confusion, loss of consciousness, or severe low-blood-sugar symptoms in a diabetic patient |
| New or worsening mood changes, anxiety, or depression | Chest pain, sudden weakness or numbness, or symptoms of stroke |
| Changes in vision | Signs of a serious infection with fever and severe pain |
If you have questions about a symptom that isn’t clearly an emergency, connect with your care team through a telehealth visit for chronic condition monitoring, or reach out to Windermere Medical Group’s GLP-1 weight loss treatment program directly.
Frequently Asked Questions (FAQ)
The top number, systolic pressure, measures the force in your arteries when your heart beats. The bottom number, diastolic pressure, measures the pressure between beats when your heart rests. Both numbers matter, and your provider reviews them together, not separately.
The FDA reviewed reports of suicidal thoughts in patients taking GLP-1 medications including semaglutide, and in its January 2024 safety communication stated that a causal link has not been established. The agency continues to monitor. Anyone experiencing mood changes on Ozempic should contact their provider.
For most people, nausea is worst in the first few weeks of treatment and after each dose increase, then improves as the body adjusts. Some people feel it primarily in the day or two after their weekly injection. If nausea is intense enough to disrupt daily life, your provider can adjust your dose or titration.
The FDA label does not list an outright prohibition on alcohol, but alcohol can worsen nausea, affect blood sugar (especially for people with diabetes), and add strain on the pancreas. Talk with your provider about your specific situation. Many people find it helpful to reduce alcohol intake while their body adjusts to the medication.
Yes, largely. Ozempic and Wegovy both contain semaglutide, made by the same manufacturer, and they share the same broad side-effect profile. Wegovy uses higher maintenance doses for chronic weight management, which can make gastrointestinal side effects more common, but the categories of possible effects are the same.
